VERTEX PHARMACEUTICALS INC / MA Earnings Per Share, Basic and Diluted
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Earnings Per Share, Basic and Diluted of -$0.30 per share for the 3-month period ending 2015-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-02-23
- VERTEX PHARMACEUTICALS INC / MA earnings per share, basic and diluted for the quarter ending 2015-12-31 was -$0.30.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, basic and diluted for the quarter ending 2015-09-30 was -$0.39.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, basic and diluted for the quarter ending 2015-06-30 was -$0.78.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, basic and diluted for the quarter ending 2015-03-31 was -$0.83.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|
| 2015-12-31 | -$0.30 10-K · filed 2017-02-23 | -$2.31 derived: net income ÷ weighted average shares · filed 2018-02-15 | |
| 2015-09-30 | -$0.39 10-K · filed 2017-02-23 | ||
| 2015-06-30 | -$0.78 10-K · filed 2017-02-23 | ||
| 2015-03-31 | -$0.83 10-K · filed 2017-02-23 | ||
| 2014-12-31 | -$0.74 10-K · filed 2016-02-16 | -$3.14 derived: net income ÷ weighted average shares · filed 2016-02-16 | |
| 2014-09-30 | -$0.72 10-K · filed 2016-02-16 | ||
| 2014-06-30 | -$0.68 10-K · filed 2016-02-16 | ||
| 2014-03-31 | -$1.00 10-K · filed 2016-02-16 | ||
| 2013-12-31 | $0.19 10-K · filed 2015-02-13 | -$2.24 derived: net income ÷ weighted average shares · filed 2015-02-13 | |
| 2013-09-30 | -$0.54 10-K · filed 2015-02-13 | ||
| 2013-06-30 | -$0.26 10-K · filed 2015-02-13 | -$1.67 derived: net income ÷ weighted average shares · filed 2015-02-13 | |
| 2013-03-31 | -$1.43 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |